EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Aptevo Therapeutics Inc. (APVO) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-9.03M |
|
-- |
|
-- |
|
$7.61M |
|
$-7.61M |
|
$0.06M |
|
$-7.55M |
|
$-7.55M |
|
$-7.55M |
|
$-7.55M |
|
$-7.55M |
|
$-7.55M |
|
$-7.61M |
|
$-7.56M |
|
4.05M |
|
4.05M |
|
$-2.23 |
|
$-2.23 |
|
| Balance Sheet Financials | |
$22.65M |
|
$0.38M |
|
$4.35M |
|
$27.00M |
|
$5.61M |
|
-- |
|
$3.99M |
|
$9.60M |
|
$17.39M |
|
$17.39M |
|
$17.39M |
|
13.81M |
|
| Cash Flow Statement Financials | |
$-20.36M |
|
-- |
|
$32.70M |
|
$8.71M |
|
$21.06M |
|
$12.35M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-20.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.41% |
|
-43.41% |
|
-27.96% |
|
-43.41% |
|
$1.26 |
|
$-5.03 |
|
$-5.03 |
|